Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 26, 2009, Pages 10746-10751

  Ueda, Ryo ^a,b   Kohanbash, Gary ^b   Sasaki, Kotaro ^a,b   Fujita, Mitsugu ^a,b   Zhu, Xinmei ^a,b   Kastenhuber, Edward R ^b   McDonald, Heather A ^b   Potter, Douglas M ^b,c   Hamilton, Ronald L ^a,b,c   Lotze, Michael T ^a   Khan, Saleem A ^a   Sobol, Robert W ^a,b   Okada, Hideho ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Dicer; Glioma

Indexed keywords

DICER; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MICRORNA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOLOGY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; FEMALE; GENE DISRUPTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA PROCESSING; UNTRANSLATED REGION;

BLOTTING, WESTERN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CYTOTOXICITY, IMMUNOLOGIC; DEAD-BOX RNA HELICASES; DOWN-REGULATION; FLOW CYTOMETRY; GLIOBLASTOMA; HCT116 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERCELLULAR ADHESION MOLECULE-1; LUCIFERASES; MICRORNAS; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASE III; RNA INTERFERENCE; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 67649814967     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0811817106     Document Type: Article

References (41)

1. Grimson A, et al. (2007) MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell 27:91-105. (Pubitemid 46991392)
2. Chiosea S, et al. (2006) Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol 169:1812-1820. (Pubitemid 351182010)
3. Chiosea S, et al. (2007) Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res 67:2345-2350. (Pubitemid 46424256)
4. Takamizawa J, et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64:3753-3756. (Pubitemid 38697282)
5. Fabbri M, Croce, CM, Calin, GA (2008) MicroRNAs. Cancer J 14:1-6.
6. Karube Y, et al. (2005) Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 96:111-115. (Pubitemid 40425386)
7. Cummins JM, et al. (2006) The colorectal microRNAome. Proc Natl Acad Sci USA 103:3687-3692.
8. Cobb BS, et al. (2006) A role for Dicer in immune regulation. J Exp Med 203:2519-2527.
9. Muljo SA, et al. (2005) Aberrant T cell differentiation in the absence of Dicer. J Exp Med 202:261-269. (Pubitemid 41043822)
10. Kemp RA, Ronchese F (2001) Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity. J Immunol 167:6497-6502. (Pubitemid 33081584)
11. CBTRUS (2008) The Central Brain Tumor Registry of the United States Statistical Report: Primary Brain Tumors in the United States, 2000-2004 (Central Brain Tumor Registry of the United States, Hinsdale, IL). Available at www.cbtrus.org/reports//2007-2008/2007report.pdf. Accessed June 5, 2009.
12. Stupp R, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996. (Pubitemid 40349501)
13. Elmen J, et al. (2008) LNA-mediated microRNA silencing in non-human primates. Nature 452:896-899. (Pubitemid 351550859)
14. Hatano M, et al. (2005) EphA2 as a glioma-associated antigen: a novel target for glioma vaccines. Neoplasia 7:717-722.
15. Eguchi J, et al. (2006) Identification of interleukin-13 receptor alpha2 peptide analogues capable of inducing improved antiglioma CTL responses. Cancer Res 66:5883-5891. (Pubitemid 43927143)
16. Morrison J, et al. (1992) Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Eur J Immunol 22:903-907.
17. Vujanovic L, et al. (2008) Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus. Cancer Immunol Immunother 58:121-133.
18. Bachmann MF, et al. (1997) Distinct roles for LFA-1 and CD28 during activation of naive T cells: Adhesion versus costimulation. Immunity 7:549-557. (Pubitemid 27508706)
19. Jenkinson SR, Williams NA, Morgan DJ (2005) The role of intercellular adhesion molecule-1/LFA-1 interactions in the generation of tumor-specific CD8+ T cell responses. J Immunol 174:3401-3407. (Pubitemid 40354045)
20. Gillies JK, Lorimer IA (2007) Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle 6:2005-2009.
21. Tokumaru S, et al. (2008) let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 29:2073-2077.
22. Gaur A, et al. (2007) Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67:2456-2468. (Pubitemid 46548930)
23. Lu J, et al. (2005) MicroRNA expression profiles classify-humancancers. Nature 435:834-838.
24. Volinia S, et al. (2006) AmicroRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-2261. (Pubitemid 43271657)
25. Visone R, et al. (2007) MicroRNAs (miR)-221 and miR-222, both overexpressed inhuman thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 14:791-798. (Pubitemid 350074067)
26. Felicetti F, et al. (2008) The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 68:2745-2754. (Pubitemid 351556272)
27. Ciafre SA, et al. (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334:1351-1358. (Pubitemid 41074723)
28. Medina R, et al. (2008) MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Res 68:2773-2780. (Pubitemid 351556275)
29. Corsten MF, et al. (2007) MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67:8994-9000. (Pubitemid 47535880)
30. Anastassiou G, et al. (2000) Expression of the cell adhesion molecules ICAM-1, VCAM-1 and NCAM in uveal melanoma: a clinicopathological study. Oncology (Basel) 58:83-88. (Pubitemid 30045314)
31. Shirai A, Furukawa M, Yoshizaki T (2003) Expression of intercellular adhesion molecule (ICAM)-1 in adenoid cystic carcinoma of the head and neck. Laryngoscope 113:1955-1960. (Pubitemid 37409684)
32. Ogawa Y, et al. (1998) Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis. Clin Cancer Res 4:31-36. (Pubitemid 28062874)
33. Shibata MAK, Amano S, Kurosu Y (1996) Local expression and circulating form of ICAM-1 in colorectal cancer. Ann Cancer Res Ther 5:29-33.
34. Arnold JM, Cummings M, Purdie D, Chenevix-Trench G (2001) Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas. Br J Cancer 85:1351-1358. (Pubitemid 33081932)
35. Poggi A, et al. (2007) NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells. Ann NY Acad Sci 1109:47-57. (Pubitemid 47511344)
36. Tang KF, et al. (2008) Decreased Dicer expression elicits DNA damage and upregulation of MICA and MICB. J Cell Biol 182:233-239.
37. Ueda R, et al. (2007) Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma. J Transl Med 5:68. (Pubitemid 351276812)
38. Livak KJ, SchmittgenTD(2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (Amsterdam, Neth.) 25:402-408.
39. Baldwin RM, et al. (2006) Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling. Oncogene 25:2909-2919. (Pubitemid 43739241)
40. Hatano M, et al. (2004) Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors. J Transl Med 2:40. (Pubitemid 40617850)
41. Obernosterer G, Martinez J, Alenius M (2007) Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections. Nat Protoc 2:1508-1514. (Pubitemid 46952329)